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Abstract: The triacylglycerol lowering effect of fatty fish and fish oils is well recognized, however we
recently showed that salmon intake resulted in higher serum triacylglycerol concentration in obese
Zucker fa/fa rats. Since effects of salmon fillet have never before been studied in rats, the objective of
this study was to compare effects of salmon intake on serum lipids in hyperlipidemic obese rats with
normolipidemic lean rats. Zucker fa/fa rats and Long-Evans rats were fed diets with 25% protein from
baked salmon fillet and 75% protein from casein, or casein as sole protein source (control group) for
four weeks. Serum triacylglycerol concentration was higher, and cholesterol and apolipoproteinB-100
concentrations were lower in Zucker fa/fa rats fed Baked Salmon Diet compared to Zucker fa/fa rats
fed Control Diet, with no differences in serum triacylglycerol, cholesterol and apolipoproteinB-100
between Long-Evans rats fed Baked Salmon Diet or Control Diet. Serum triacylglycerol fatty acid
composition showed greater similarities to dietary fatty acids in Zucker fa/fa rats than in Long-Evans
rats. To conclude, intake of baked salmon fillet resulted in higher serum triacylglycerol concentration
and lower serum cholesterol concentration in hyperlipidemic obese Zucker fa/fa rats but did not
affect serum lipids in normolipidemic lean Long-Evans rats.
Keywords: n-3 PUFA; salmon; fatty fish; apoB48; apoB100; triacylglycerols; phospholipids; fatty acids;
Zucker fa/fa rat; Long-Evans rat
1. Introduction
Elevated concentrations of fasting and non-fasting triacylglycerols are independent risk factors of
cardiovascular disease [1]. Intake of long chain n-3 PUFAs has been found to have cardio protective
effects, especially in patients with dyslipidemia [2]. The reduction in circulating triacylglycerol is
considered the most consistent effect of n-3 PUFA consumption [3–18], but there is controversy as
to the cholesterol-regulating effects of the marine n-3 fatty acids [9,11,13–16,19–21]. Several types of
hyperlipidemia were defined by Fredrickson and Lees [22], with elevated concentrations of various
types of lipids and lipoproteins. In the context of the present paper, Types I and V hyperlipidemia are
of special interest. Type I hyperlipidemia is characterized by severely elevated levels of chylomicrons,
and thus high circulating levels of cholesterol and especially triacylglycerols, and is caused by
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mutations of either the gene for lipoprotein lipase or its cofactor apolipoprotein C-II [22]. In patients
with Type V hyperlipidemia, concentrations of both chylomicrons and VLDL are elevated, accompanied
with elevated serum levels of cholesterol and both endogenous and exogenous triacylglycerols,
with normal or modestly reduced lipoprotein lipase activity [22].
The obese Zucker fa/fa rat is a much used animal model for studies of metabolic complications and
possible treatments of obesity, since it has an abnormal lipid metabolism and presents changes often
seen in human obesity [23]. Visible obesity is present already 3–5 weeks after birth, and in addition the
obese Zucker rats develop a range of endocrine abnormalities resembling human metabolic syndrome,
including insulin resistance, dyslipidemia, mild glucose intolerance and hyperinsulinemia [23].
The obese Zucker fa/fa rat may be an interesting model for hyperlipidemias of Type I and V, as it
has an elevated secretion of triacylglycerols in VLDL from liver combined with a slow clearance
of chylomicrons, resulting in high circulating concentrations of VLDL and chylomicrons, and
consequently high levels of lipids including triacylglycerols and cholesterol compared to metabolic
healthy rats [24,25].
We have recently shown that, when obese Zucker fa/fa rats were fed a diet containing 25% of the
protein from baked salmon fillet, it resulted in a significantly higher serum triacylglycerol concentration
when compared to a standard control diet with casein as the sole protein source [26]. To our best
knowledge, this is the first study on salmon fillet fed to two different rat strains. Since n-3 PUFA
consumption has been repeatedly shown to reduce circulating triacylglycerol concentration [3–18],
the objective of the present study was to compare the effects of intake of baked salmon on serum lipids
in hyperlipidemic obese Zucker fa/fa rats with that of lean Long-Evans rats which have normal lipid
metabolism. Our hypothesis was that the high serum triacylglycerol concentration in obese Zucker
fa/fa rats fed salmon diet was a consequence of the slow clearance of chylomicrons in these rats [24,25]
and thus the fatty acid composition in serum triacylglycerols would be a reflection of the dietary
fatty acids. Thus, we did not expect differences in serum lipids and apoBs concentrations between
Long-Evans rats fed baked salmon fillet and control diet since these rats have normal lipid metabolism.
2. Materials and Methods
2.1. Ethical Statement
The study protocol was approved by the National Animal Research Authority of Norway,
in accordance with the Animal Welfare Act and the regulation of animal experiments (approval
no 2014–6979). The animal care and use program at the Faculty of Medicine at University of
Bergen is accredited by the Association for Assessment and Accreditation of Laboratory Animal
Care International.
2.2. Design
Two experiments were conducted. In the first experiment, twelve male Zucker fa/fa rats
(HsdHlr:ZUCKER-Leprfa, from Harlan Laboratories, Indianapolis, IN, USA) were assigned to two
experimental groups of six rats each with comparable mean bodyweight. Some data from this
experiment, including serum lipids, have already been published in Vikøren et al. [26] and Vikøren
et al. [27], and the finding that a Baked Salmon Diet resulted in a significantly higher serum
triacylglycerol concentration when compared to a standard Control Diet in obese Zucker fa/fa rats
was the background for comparing these diets in another rat model. Therefore, in a second experiment,
twelve male Long-Evans rats (Crl:LE, from Charles River Laboratories, Calco, Italy) were assigned
to two experimental groups of six rats each with comparable mean bodyweight. The rats in the two
experiments were treated in the exact same manner and therefore the designs of the two experiments
are presented together. Rats were housed in pairs in a room maintained at a 12 h light–dark cycle (light
from 07:00 to 19:00) with constant temperature of 20 ± 3 ◦C and relative humidity of 65 ± 15%. The rats
were acclimatized for at least one week under these conditions before the start of the experiments.
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The intervention period in the Zucker fa/fa rat study started when the rats weighed 350 ± 20 g
(i.e., 8–9 weeks old), and after the four-week intervention period the Zucker fa/fa rats weighed
554 ± 26 g. To make certain that differences in serum lipids between the strains were not a consequence
of differences in bodyweights, we wanted the Long-Evans rats to reach a similar bodyweight as
the Zucker rats after four-week intervention, and based on the growth chart from Charles River
Laboratories the starting weight of the Long-Evans rats should be around 440 g. The intervention
in the Long-Evans rat study started when the rats weighed 430 ± 30 g (i.e., when the rats were
13–15 weeks old) and the mean body weight for all Long-Evans rats at endpoint was 572 ± 38 g.
Rats were weighed weekly during the intervention period. One week before euthanasia, rats were
housed individually in cages with grids for 24 h without fasting in advance for measurements of
feed intake.
2.3. Diets
The rats were fed modified, semi-purified experimental diets prepared according to the
instructions for the AIN-93G [28] with addition of 1.6 g methionine/kg diet as recommended by
Reeves [29] (Table 1) for four weeks. The Control Diet contained 20 wt % proteins from casein
(Sigma-Aldrich, Munich, Germany). Skin free salmon fillets from Atlantic Salmon (farmed Salmo salar,
fed 6% EPA+DHA of fatty acids until 1200 g bodyweight and 4.5% EPA+DHA in following feeds [30])
were provided by Leroy Seafood Group (Hordaland, Norway). Baked salmon filets were prepared in
oven at 180 ◦C for 20 min (no oil or fat were added when baking the fish) and were minced, freeze
dried and grinded before it was mixed with the other ingredients in the diets. All other ingredients
were purchased from Dyets Inc. (Bethlehem, PA, USA). All rats had free access to tap water and feed
(ad libitum). The feed was contained in ceramic bowls that were too heavy for the rats to knock over.
Feed leftovers were thrown away and newly thawed feed were provided every day. Since the feed
was given as a powder formula, the rats had access to wood chewing sticks.
Table 1. Composition of the experimental diets.
g/kg Diet Control Diet Baked Salmon Diet
Casein protein 1 216.2 162.2




Soybean Oil 70.0 70.0
t-Butylhydroquinone 0.014 0.014
Mineral Mix (AIN-93-MX) 35.0 35.0
Vitamin Mix (AIN-93-VX) 10.0 10.0
L-Methionine 1.60 1.60
L-Cystine 3.0 3.0
Choline Bitartrate 3 2.5 2.5
Growth and Maintenance Supplement 4 10.0 10.0
1 Contains 92.5% crude protein; 2 contains 50% crude protein; 3 contains 41% choline; 4 contains vitamin B12
(40 mg/kg) and vitamin K1 (25 mg/kg) mixed with sucrose (995 g/kg) and dextrose (5 g/kg).
2.4. Euthanasia and Sampling
The rats were euthanized while under anesthesia with isoflurane (Isoba vet, Intervet,
Schering-Plough Animal Health, Boxmeer, The Netherlands) mixed with nitrous oxide and oxygen
after four-week intervention, after a 12-h fast with free access to tap water. Blood was drawn directly
from the heart and collected in Vacuette Z Serum Clot Activator Tubes (Greiner Bio-one) for isolation
of serum. Epididymal, renal and retroperitoneal white adipose tissues (WAT) were dissected out and
weighed. Serum and WAT were snap-frozen in liquid nitrogen and stored at −80 ◦C until analysis.
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2.5. Analyses of Diets
The dietary contents of amino acids, total fat (Folch extraction) and total energy in the diets
were analyzed by Nofima BioLab (Bergen, Norway), and the fatty acid composition in the diets were
analyzed by gas chromatography as previously described [31–35], and have been published earlier [26].
In brief, the dietary contents of indispensable amino acids were in general similar in Control Diet and
Baked Salmon Diet, whereas taurine was found only in the Baked Salmon Diet. The Baked Salmon
Diet contained higher amounts of 16:0, 18:0, 18:1n−7, 18:1n−9, 18:2n−6 and 18:3n−3 when compared
to the Control Diet, and the long chain n−3 PUFAs 20:5n−3, 22:5n−3 and 22:6n−3 were found only in
the Baked Salmon Diet (Table 2).
Table 2. Fatty acid contents in the experimental diets 1.










1 Showing fatty acids present in amounts >0.2 g/kg, ND; not detected.
2.6. Analyses in Serum
Fasting serum concentrations of triacylglycerols, total cholesterol, LDL cholesterol,
HDL cholesterol, alanine transaminase and total bile acids were analyzed by accredited methods
at the Laboratory of Clinical Biochemistry at Haukeland University Hospital (Bergen, Norway)
on the Cobas 8000 c702 module from Roche Diagnostics GmbH, Mannheim, Germany using the
TRIGL, CHOL2, LDL_C, HDLC3 and ALTPM kits from Roche Diagnostics GmbH and the Total
bile acids assay kit from Diazyme Laboratories, Inc., Poway, CA, USA. Non-esterified fatty acids,
free cholesterol and aspartate transaminase were analyzed on the Cobas c 111 system (Roche
Diagnostics GmbH, Mannheim, Germany) using the NEFA FS kit (DiaSys, Diagnostic Systems GmbH,
Holzheim, Germany), the free cholesterol FS kit (DiaSys) and the Aspartate aminotransferase ASTL
kit (Roche Diagnostics GmbH). Serum cholesteryl ester was calculated as the difference between
total and free cholesterol. Apolipoprotein B48 and B100 were measured using the MBS753664 Rat
Apolipoprotein B48 ELISA Kit (MyBioSource Inc., San Diego, CA, USA) and the MBS723231 Rat
Apoprotein B100 ELISA Kit (MyBioSource). C-reactive protein (CRP) was measured with the Rat
C-Reactive Protein ELISA kit (#88-7501, from Invitrogen by Thermo Fisher Scientific Inc., Carlsbad, CA,
USA). Serum insulin was measured with the Insulin (Rat) Elisa kit (EIA-2048, from DRG Instruments
GmbH, Marburg, Germany). Serum concentrations of triacylglycerol, total cholesterol, LDL cholesterol,
HDL cholesterol, total bile acids, NEFA and cholesteryl ester in these Zucker fa/fa rats are previously
published [26].
2.7. Analyses of Fatty Acids in Serum Lipids
Lipids were extracted from serum by the method of Bligh and Dyer [31] using a mixture of
chloroform and methanol, and lipid classes were separated by TLC on silica gel plates (250 µm Silica
gel 60 from Merck KGaA, Darmstadt, Germany) developed in hexane–diethyl ether–acetic acid (40:10:1,
by vol) [36]. The triacylglycerols and phospholipids spots were identified using Rhodamine G (Fluka
Chemie AG, Buchs, Switzerland) and co-migration with known standards, and were scraped off,
methylated and analyzed as described previously [32–35].
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2.8. Statistical Analysis
Statistical analyses were conducted using SPSS Statistics version 25 (SPSS, Inc., IBM Company,
Armonk, NY, USA). Groups within rat strains were compared using Independent Samples T
Test assuming equal variances. One-way ANOVA was used to compare bodyweight at baseline,
bodyweight at endpoint and energy intake for all groups (strain and diets), with Tukey HSD post
hoc test when appropriate. The cut-off level for statistical significance was taken at a probability of
0.05. Rats fed a casein-based diet served as controls in both experiments. One Zucker fa/fa rat in the
Control Group in the first experiment had to be euthanized due to a serious lesion and poor health in
the first week of the study and is not included in the results, therefore n = 5 in the Control Group and
n = 6 in the Baked Salmon Group. In the second experiment (Long-Evans rats), n = 6 in both Baked
Salmon Group and Control Group. Data are presented as mean ± standard deviation.
3. Results
3.1. Bodyweight, Growth, White Adipose Tissue Weight, and Energy and Fat Intake
The mean bodyweight at baseline was similar between Zucker fa/fa rats in Baked Salmon
Group and in Control Group (p = 0.85), and was also similar between Long-Evans rats in Baked
Salmon Group and in Control Group (p = 0.92, Figure 1). The study was designed so that the Zucker
fa/fa rats and the Long-Evans rats would reach the same bodyweight after four-week intervention,
based on the growth charts from the breeders showing a much steeper growth curve for obese Zucker
fa/fa rats, and therefore the bodyweight at baseline was significantly higher in the Long-Evans rats
(p ANOVA = 2.2 × 10−5). At endpoint (four weeks), the mean bodyweight was similar in all groups
(p ANOVA = 0.062). The mean bodyweights were similar between Zucker fa/fa rats fed Control Diet
and Baked Salmon Diet, and between Long-Evans rat fed Control Diet and Baked Salmon Diet after
one, two, three and four weeks (Figure 1).
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Figure 1. Bodyweight development (grams) in obese Zucker fa/fa rats and Long-Evans rats, shown as 
mean values with standard deviations, for n = 5 in Zucker fa/fa Control Group, and n = 6 in all other 
groups. No differences were seen at any time points within any of the rat strains. p < 0.05 was 
considered significant. Groups within rat strains are compared using Independent Samples T Test 
assuming equal variances. 
The relative WAT-to-bodyweight ratio was similar in Zucker fa/fa rats fed Baked Salmon Diet 
or Control Diet, and was also similar in Long-Evans rats fed Baked Salmon Diet or Control Diet, but 
Zucker fa/fa rats had significantly more WAT compared to Long-Evans rats, independent of diets (p 
ANOVA = 8.9 × 10−4) (Table 3). The mean daily energy intake was similar in all groups (p ANOVA = 
0.24), however the daily fat intake was significantly higher in both Zucker fa/fa rats and Long-Evans 
rats fed Baked Salmon Diet when compared to their respective control group. 
Table 3. Relative weight of WAT, energy intake, and fat intake is a table.  
Values are mean and standard deviations, n = 5 in Zucker fa/fa Control Group, and n = 6 in all other 
groups. p < 0.05 was considered significant. Groups within rat strains are compared using 
Independent Samples T Test assuming equal variances. 1 The sum of epididymal, renal and 
retroperitoneal white adipose tissue from both sides of the rat, relative to bodyweight. 
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of WAT 1, g/100 g 
bodyweight 
7.43 ± 0.75 7.58 ± 0.80 0.77 4.97 ± 0.90 5.80 ± 1.32 0.23 
Energy intake, 
kcal/24 h 
144 ± 17 126 ± 20 0.15 123 ± 18 122 ± 21 0.91 
Fat intake, g/24 h 2.7 ± 0.3 3.3 ± 0.5 0.045 2.3 ± 0.3 3.2 ± 0.5 0.0062 
Figure 1. Bodyweight development (grams) in obese Zucker fa/fa rats and Long-Evans rats, shown as
mean values with standard deviations, for n = 5 in Zucker fa/fa Control Group, and n = 6 in all
other groups. No differences w re seen at a y time points within any of the rat strains. p < 0.05 was
considered significant. Groups within rat s rains are compared using Independent Samples T Test
assumi g equal variances.
The relative WAT-to-bodyweight ratio was similar in Zucker fa/fa rats fed Baked Salmon Diet
or Control Diet, and was also similar in Long-Evans rats fed Baked Salmon Diet or Control Diet,
but Zucker fa/fa rats had significantly more WAT compared to Long-Evans rats, independent of diets
(p ANOVA = 8.9 × 10−4) (Table 3). The mean daily energy intake was similar in all groups (p ANOVA
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= 0.24), however the daily fat intake was significantly higher in both Zucker fa/fa rats and Long-Evans
rats fed Baked Salmon Diet when compared to their respective control group.
Table 3. Relative weight of WAT, energy intake, and fat intake is a table.










WAT 1, g/100 g
bodyweight
7.43 ± 0.75 7.58 ± 0.80 0.77 4.97 ± 0.90 5.80 ± 1.32 0.23
Energy intake,
kcal/24 h 144 ± 17 126 ± 20 0.15 123 ± 18 122 ± 21 0.91
Fat intake, g/24 h 2.7 ± 0.3 3.3 ± 0.5 0.045 2.3 ± 0.3 3.2 ± 0.5 0.0062
Values are mean and standard deviations, n = 5 in Zucker fa/fa Control Group, and n = 6 in all other groups. p < 0.05
was considered significant. Groups within rat strains are compared using Independent Samples T Test assuming
equal variances. 1 The sum of epididymal, renal and retroperitoneal white adipose tissue from both sides of the rat,
relative to bodyweight.
3.2. Serum Analyses
In the Zucker fa/fa rat experiment, rats fed Baked Salmon Diet had significantly higher serum
concentration of triacylglycerols, as we have previously published [26], whereas no differences
were seen in serum concentrations of triacylglycerols between the Control Group and the Baked
Salmon Group in the Long-Evans rat experiment (Figure 2). Zucker fa/fa rats fed Baked Salmon Diet
had significantly lower serum concentrations of total cholesterol, HDL cholesterol, LDL cholesterol,
cholesteryl ester and total bile acids when compared to those fed Control Diet, with no difference
between the groups for serum NEFA concentration (Table 4), as we have previously published [26].
In contrast, in the Long-Evans rat experiment no differences were seen in serum concentrations of total
cholesterol, HDL cholesterol, LDL cholesterol, cholesteryl ester and total bile acids between rats fed the
Baked Salmon Diet or the Control Diet, however serum NEFA concentration was significantly lower in
the Baked Salmon Group. Serum concentrations of triacylglycerols, total cholesterol, HDL cholesterol,
LDL cholesterol, cholesteryl ester and total bile acids were significantly higher in Zucker fa/fa rats fed
Control Diet when compared to Long-Evans rats fed the same diet (all p values < 1.0 × 10−3).
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mmol/L 6.3 ± 0.6 4.9 ± 0.8 0.011 2.9 ± 0.3 2.8 ± 0.5 0.58 
HDL cholesterol, 
mmol/L 5.3 ± 0.3 2.7 ± 0.2 4.4 × 10
−8 2.5 ± 0.2 2.3 ± 0.2 0.18 
LDL cholesterol, 
mmol/L 1.5 ± 0.3 0.9 ± 0.3 0.0025 0.7 ± 0.1 0.6 ± 0.1 0.21 
Cholesteryl ester, 
mmol/L 4.9 ± 0.5 3.7 ± 0.5 0.0045 2.2 ± 0.2 2.2 ± 0.4 0.74 
Figure 2. Serum triacylglycerols in obese Zucker fa/fa rats and Long-Evans rats, shown as mean
values with standard deviation , for n = 5 in Zucker f /f Control Group, nd n = 6 in all other groups.
p values are shown for comparisons within rat strains. p < 0.05 w s considered significant. Groups
within rat strains are compared using Independent Samples T Test assuming equal variances.
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Table 4. Serum concentrations of lipids, total bile acids, apolipoproteins B48 and B100, and CRP.










mmol/L 6.3 ± 0.6 4.9 ± 0.8 0.011 2.9 ± 0.3 2.8 ± 0.5 0.58
HDL cholesterol,
mmol/L 5.3 ± 0.3 2.7 ± 0.2 4.4 × 10
−8 2.5 ± 0.2 2.3 ± 0.2 0.18
LDL cholesterol,
mmol/L 1.5 ± 0.3 0.9 ± 0.3 0.0025 0.7 ± 0.1 0.6 ± 0.1 0.21
Cholesteryl ester,
mmol/L 4.9 ± 0.5 3.7 ± 0.5 0.0045 2.2 ± 0.2 2.2 ± 0.4 0.74
Total bile acids,
umol/L 46 ± 21 16 ± 7 0.0084 7 ± 5 5 ± 4 0.44
NEFA, mmol/L 0.91 ± 0.13 0.84 ± 0.12 0.38 0.43 ± 0.18 0.19 ± 0.14 0.030
ApoB-100, ng/mL 163 ± 53 96 ± 32 0.036 61 ± 6 68 ± 11 0.22
ApoB-48, ng/mL 7 ± 3 10 ± 3 0.12 20 ± 3 21 ± 4 0.69
CRP, mg/mL 1.18 ± 0.08 0.96 ± 0.14 0.014 0.96 ± 0.05 0.98 ± 0.07 0.62
Values are mean and standard deviations, n = 5 in Zucker fa/fa Control Group, and n = 6 in all other groups. p < 0.05
was considered significant. Groups within rat strains are compared using Independent Samples T Test assuming
equal variances. HDL, high-density lipoprotein; LDL, low-density lipoprotein; NEFA, non-esterified fatty acids;
Apo, apolipoprotein; CRP, C-reactive protein.
Serum apoB-48 concentrations were not different between Zucker fa/fa rats fed Baked Salmon
Diet or Control Diet, whereas the serum concentration of ApoB-100 was significantly lower in Zucker
fa/fa rats fed Baked Salmon Diet when compared to those fed Control Diet (Table 4). ApoB-48 and
apoB-100 serum concentrations were similar between Long-Evans rats fed Control Diet or Baked
Salmon Diet. Fasting insulin was measured only in Zucker fa/fa rats, and showed no difference
between the dietary groups (Control Group 9.4 ± 7.1 µg/L; Baked Salmon Group 4.8 ± 2.3 µg/L,
p = 0.16).
In Long-Evans rats, no differences were seen between the dietary groups for serum concentrations
of alanine transaminase, aspartate transaminase (p values of 0.79 and 0.97, respectively, data not
presented) and CRP (Table 4), whereas serum concentration CRP was significantly lower in Zucker
fa/fa rats fed Baked Salmon Diet when compared to Zucker fa/fa rats fed Control Diet (Table 4). Serum
concentration of aspartate transaminase was significantly lower in Zucker fa/fa rats fed Baked Salmon
Diet when compared to Zucker fa/fa rats fed Control Diet (p = 0.017), whereas no difference was seen
between the Zucker fa/fa diet groups in regard to alanine transaminase concentration (p value 0.28),
as we have previously published [27]. When serum concentrations of alanine transaminase, aspartate
transaminase and CRP were compared between Zucker fa/fa rats and Long-Evans rats fed Control
Diet, concentrations were significantly higher in Zucker fa/fa rats (all p values < 1.0 × 10−3).
3.3. Fatty Acids in Triacylglycerols and Phospholipids in Serum
As would be expected from the higher serum triacylglycerol concentration in Zucker fa/fa rats
fed Baked Salmon Diet when compared to those fed Control Diet, the sum of fatty acids esterified as
triacylglycerols were significantly higher in the Baked Salmon Group compared to the Control Group
(343 ± 104 and 203 ± 59 µg/100 µL serum, respectively, p = 0.026), with no difference between
these two groups for the total amount of fatty acids esterified as phospholipids (214 ± 32 and
225 ± 9 µg/100 µL serum, respectively, p = 0.49, Figure 3). In Long-Evans rats, no differences were
seen in the sum of fatty acids esterified as triacylglycerols and phospholipids between Baked Salmon
Group and Control Group (p values of 0.67 and 0.96, respectively).
In Zucker fa/fa rats, the higher amount of fatty acids as serum triacylglycerols in Baked Salmon
Group when compared to Control Diet seems to originate from the diet (p = 0.018, Figure 3A), with no
difference between these groups when comparing fatty acids esterified as triacylglycerols that were
not identified in the diets (p = 0.26). In regard to fatty acids esterified as phospholipids in serum,
no difference was seen between the Zucker fa/fa diet groups for fatty acids that were identified in the
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diets (p = 0.23, Figure 3B), however a significantly lower amount of fatty acids not found in the diets
were esterified as phospholipids in serum of Zucker fa/fa rats fed Baked Salmon Diet (p = 6.7 × 10−4).
In Long-Evans rats, no difference was seen between the Control Diet and the Baked Salmon Diet
for fatty acids esterified as triacylglycerols, and this applied both to those fatty acids that were found
in the diets (p = 0.52) and those that were not found in the diets (p = 0.32). In addition, comparable
amounts of fatty acids found in the diets were esterified as phospholipids in Long-Evans rats fed
Baked Salmon Diet or Control Diet (p = 0.23), whereas a significantly lower amount of fatty acids not
found in the diets were esterified as phospholipids in Long-Evans rats fed Baked Salmon Diet when
compared to those fed the Control Diet (p = 0.039).
The relative amounts of individual fatty acids esterified as triacylglycerols and phospholipids are
presented in Table S1. Of special interest in the current setting is the effect of salmon diet on long-chain
n−3 PUFAs, showing that intake of Baked Salmon Diet led to significantly higher amounts of 20:5n−3,
22:6n−3 and total n−3 PUFAs as triacylglycerols and phospholipids in both rat strains. In addition,
both Zucker fa/fa rats and Long-Evans rats fed Baked Salmon Diet had significantly higher amounts
of 22:5n−3 in triacylglycerols, while Long-Evans rats but not Zucker fa/fa rats fed Baked Salmon diet
had more 22:5n−3 in phospholipids when compared to their respective control groups.
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mean values with standard deviations, for = 5 in Zucker fa/fa Control Group, and n = 6 in all other
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Control Group (same rat strain); $ amount of fatty acids found in the diet was significantly different
from Control Group (same rat strain); and # amount of fatty acids not found in the diet was significantly
different from Control Group (same rat strain).
4. Discussion
The present study is the first to compare the effects of a Baked Salmon Diet and a Control Diet in
two very metabolically different rat models: the obese Zucker fa/fa rat which develops dyslipidemia
and obesity at a young age [23,24] and the lean Long-Evans rat which has a normal lipid metabolism.
Our findings show that the effects of salmon intake on lipid metabolism are very different in these
two rat models even with similar bodyweight at end of study. The Zucker fa/fa rats fed the Baked
Salmon Diet had higher serum concentrations of triacylglycerols and lower concentrations of total,
HDL and LDL cholesterols, cholesteryl ester and total bile acids when compared to the Control Group,
whereas no differences were seen between the two Long Evans groups fed Baked Salmon Diet or
Control Diet in these parameters. The fatty acid composition in serum triacylglycerols reflected the
dietary fatty acids to a larger degree in the obese Zucker fa/fa rats compared to the Long-Evans rats,
and as expected, the contents of n−3 long-chain PUFA in serum triacylglycerols and phospholipids
were higher in both rat strain groups fed the Baked Salmon Diet.
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The reduction in circulating triacylglycerol is considered the most consistent effect of n-3
PUFA consumption, and beneficial effects of fish (especially fatty fish) and fish oil intake on lipid
concentrations have been reported in both humans and animal models [3–18]. We have recently shown
that, when these obese Zucker fa/fa rats were fed a diet containing baked salmon, it resulted in a
higher serum triacylglycerol concentration when compared to a control diet containing casein and soy
oil as the only sources of protein and fat [26]. This inspired us to repeat the experiment in Long-Evans
rats which have a normal lipid metabolism, and to expand the analyses to include quantification of
apolipoproteins and fatty acids in isolated serum triacylglycerols and phospholipids.
Zucker fa/fa rats are said to be hyperphagic [23], however in the present study the daily energy
intake was similar to that of Long-Evans rats, with no differences between the dietary groups within
each rat strain. Also, since the Baked Salmon Diet contained more fat than the Control Diet, the daily
fat intake was higher in both rat strains fed salmon diet when compared to controls. Still, bodyweight
was similar between all groups at endpoint, as anticipated, with higher relative amount of body fat in
the Zucker fa/fa rats compared to Long-Evans rats and no apparent effect on adiposity after salmon
intake was observed in either rat strains.
The obese Zucker fa/fa rat and the Long-Evans rat are two metabolically different rat strains,
as was evident from the much higher adiposity and serum concentrations of lipids, CRP, alanine
transaminase and aspartate transaminase observed in the Zucker fa/fa rats, in addition to the
differences in serum triacylglycerol and phospholipid fatty acid compositions. It is well known
that the high hepatic secretion of triacylglycerols and a low clearance of chylomicrons combined with
low lipoprotein lipase activity in brown adipose tissue, skeletal muscle and cardiac muscle make
the Zucker fa/fa rat hypertriglyceridemic at a young age. In contrast, the lipid metabolism in the
Long-Evans rat is believed to be normal. Although Zucker fa/fa rats have high lipoprotein lipase
activity in white adipose tissue, it is evident that the high lipoprotein lipase activity in WAT is not
sufficient to compensate for the elevated hepatic triacylglycerol secretion [24,25]. The Zucker fa/fa
rat is of great interest as a model of hyperlipidemia in humans, especially for type I and V which are
characterized by elevated serum levels of chylomicrons (types I and V) and VLDL (type V), and low
(type I) or normal/low (type V) lipoprotein lipase activity [22]. Dyslipidemia is associated with
increased risk of developing CVD, and intake of long chain n−3 PUFAs has been shown to have cardio
protective effects, especially in patients with dyslipidemia [2].
We were surprised to find that a diet containing baked salmon actually led to a higher serum
triacylglycerol in these Zucker fa/fa rats when compared to a control diet [26]. Higher circulating
triacylglycerol concentrations in Zucker fa/fa rats have also been reported after intake of diets
containing either krill oil or fish oil, and it was suggested that this was caused by upregulation
of VLDL-secretion from liver, stimulated by long-chain n−3 PUFAs [37]. However, others have shown
that fish oil may actually reduce secretion of VLDL from the liver [38] and accelerate chylomicron
triglyceride clearance [39], and reduction in circulating triacylglycerol is indeed considered the most
consistent effect of n−3 PUFA consumption [16].
The effects of Baked Salmon Diet on serum lipids were very different between the two rat strains,
with lower serum concentrations of cholesterols and bile acids when compared to the Control Diet in
Zucker fa/fa rats, and no differences in serum lipid concentrations between Long-Evans rats fed the
two diets. In fact, the only difference in serum lipids between Long-Evans rat fed Baked Salmon Diet
and Control Diet was a lower serum NEFA concentration in the former. Several studies have shown
that fish oil intake reduces circulating NEFA concentrations [38], which is of interest since elevated
NEFA concentration is suggested to be a risk factor for cardiovascular disease [40].
The higher serum triacylglycerol in Zucker fa/fa rats fed Baked Salmon Diet when compared
to those fed the Control Diet may be a consequence of the slow clearance of chylomicrons in this
rat model [24,25], as the fatty acid content in serum triacylglycerols mirrors the dietary fatty acids
to a great extent despite a 12 h fasting period before blood samples were collected. However, since
the serum apoB-48 concentration was similar in Zucker fa/fa rats fed Baked Salmon Diet or Control
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Diet, this suggest that the number of chylomicrons may be similar in the two groups but the size of
chylomicrons may be bigger in rats fed Baked Salmon Diet, i.e. with a higher ratio of triacylglycerols
to apoB-48. The serum apoB-100 concentration was actually lower in Zucker fa/fa rats fed the Baked
Salmon Diet when compared to those fed Control Diet, possibly a consequence of reduced secretion
of VLDL from the liver caused by fish oil in the Baked Salmon Diet, as n−3 PUFA has been shown
to hamper VLDL-secretion [38]. ApoB-100 is an important apolipoprotein in both VLDL and LDL,
and the lower serum total cholesterol and LDL cholesterol concentrations in Zucker fa/fa rats fed
Baked Salmon Diet is thus in line with lower serum apoB-100 concentration. It is well known that
insulin inhibits the secretion of apoB-100 from rat hepatocytes and stimulate its degradation [41],
however no differences were seen between serum fasting concentrations of insulin in Zucker fa/fa rats
fed Baked Salmon Diet or Control Diet, further supporting the assumption that higher triacylglycerol
in Zucker fa/fa rats fed Baked Salmon Diet is caused by a combination of higher fat intake from
salmon filet and slower clearance of chylomicrons and was not a consequence of increased VLDL
secretion. Contrary to this, no differences were seen between Long-Evans rats fed the Baked Salmon
Diet and the Control Diet regarding serum concentrations of triacylglycerols, cholesterol, apoB-48 and
apoB-100, thus suggesting that the Baked Salmon Diet did not affect VLDL-secretion or degradation of
lipoproteins including chylomicrons in rats with normal lipid metabolism.
This study has some limitation. We wanted the Long-Evans rats in this follow-up study to reach
the same bodyweight as the Zucker rats after four weeks intervention, which was 554 ± 26 g, and we
achieved a mean body weight for all Long-Evans rats at endpoint of 572 ± 38 g, with no difference
between the experimental groups (p ANOVA = 0.062). Since Long-Evans rats gain weight more slowly
compared to Zucker fa/fa rats, the Long-Evans rats were older compared to Zucker fa/fa at the end of
the intervention period (17–19 weeks old vs. 12–13 weeks old). Another limitation is that, since the
Long-Evans experiment was conducted after the Zucker fa/fa study, the experimental conditions may
have been different, although we made great efforts to avoid such biases by controlling temperature,
humidity, using the same cages, using the same frozen feeds, and the same staff members handled and
euthanized the rats.
5. Conclusions
Our findings show that a diet containing baked salmon fillet had different effects on serum
triacylglycerol and cholesterol concentrations and fatty acid composition in the hyperlipidemic
obese Zucker fa/fa rat and in the normolipidemic Long-Evans rat, despite similar energy intake
and bodyweight in these two rat strains at endpoint. Zucker fa/fa rats fed the Baked Salmon Diet
had higher serum triacylglycerol concentration and lower serum cholesterol when compared to
Zucker fa/fa rats fed the Control Diet, whereas no differences were seen in serum triacylglycerol
and cholesterol concentrations between Long-Evans rats fed these two diets. Based on the findings
that fatty acids esterified as triacylglycerols had great similarities to the composition of dietary fatty
acids and the similar concentration of apoB-100 between the experimental groups in the Zucker fa/fa
experiment, the higher serum triacylglycerol concentration in Zucker fa/fa rats fed Baked Salmon Diet
may be a consequence of slow clearance of chylomicrons in this rat strain combined with more fat
originating from salmon fillet in the Baked Salmon Diet. The lower serum cholesterol concentration
combined with lower apoB-100 concentration suggest lower VLDL-secretion in Zucker fa/fa rats fed
Baked Salmon Diet, and therefore higher triacylglycerol concentration in these rats is probably not
caused by more VLDL in circulation.
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